Latest S-1 registration statements

ADM Endeavors, Inc. filed an S-1 registration statement for the resale of up to 29,000,000 common shares by GHS Investments LLC, detailing financial performance, operational expansion, and significant risks.

VisionWave Holdings, Inc. filed an S-1/A detailing an amended $50 million equity purchase agreement, recent acquisitions in AI and drone technology, and management changes, while reporting significant operating losses.

AIM ImmunoTech Inc. announced a non-transferable rights offering to raise up to $12 million through the sale of units comprising Series G Convertible Preferred Stock and warrants, while providing updates on its Ampligen clinical programs.

TV Channels Network Inc., a development-stage streaming entertainment company with no revenue, is launching an initial public offering of 3.75 million shares at $4.00 each to raise approximately $13.87 million for operations and growth.

Lendway Inc. is conducting a non-transferable subscription rights offering to raise up to $15.5 million, primarily to repay a bridge loan and strengthen its balance sheet.

Reliance Global Group announces a strategic rebranding to EZRA, a new high-tech division focused on Israeli companies, and a public offering of up to $6 million in units, while addressing Nasdaq compliance and recent asset sales.

Ambiq Micro, Inc. filed an S-1MEF to increase the number of common stock shares offered in its public offering by 551,540, including underwriter options.

K2 Capital Acquisition Corporation, a newly formed SPAC, is launching a $100 million IPO to target business combinations in humanoid robotics, physical AI, and small modular nuclear reactors.

cbdMD, Inc. registers up to 2,000,000 common shares for resale by selling shareholders, stemming from recent Series C Preferred Stock conversions, with no new proceeds for the company.

Estrella Immunopharma, Inc. filed an Amendment No. 2 to its S-1 Registration Statement, primarily updating exhibits, with its auditor noting a going concern issue.

GT Biopharma, a clinical-stage biopharmaceutical company, filed an S-1 registration statement for the resale of 22.6 million shares of common stock by existing selling stockholders, while facing Nasdaq delisting risk and going concern doubts.

Ocean Capital Acquisition Corporation, a British Virgin Islands-incorporated blank check company, filed an S-1/A for an initial public offering of 6,000,000 units at $10.00 each, aiming to raise $60 million for a business combination.

ARC Group Acquisition I Corp, a blank check company, filed an S-1/A for a $150 million initial public offering, aiming to acquire businesses with an enterprise value of $700 million or greater.

Galaxy Enterprises Inc., a development-stage real estate management firm, filed an S-1 registration statement for the resale of 3.92 million shares by existing shareholders, while auditors express substantial doubt about its ability to continue as a going concern.

Terra Property Trust, a REIT, is offering $60 million in senior secured notes due 2029 to refinance existing debt and for general corporate purposes.

Ambiq Micro, a leader in ultra-low power semiconductor solutions for edge AI, filed an S-1 registration statement for a public offering of 2.2 million shares, aiming to fund growth despite recent net losses.

Grayscale Near Trust (NEAR) has filed an S-1 registration statement with the SEC, outlining its intent to list on NYSE Arca as an ETF, detailing its investment objective, operational structure, and financial performance amidst a volatile digital asset market.

Cardiff Lexington Corporation is offering 1.5 million shares of common stock at an assumed price of $4.00 per share, contingent on its uplisting to The Nasdaq Capital Market, despite ongoing financial challenges including recurring net losses and a going concern doubt.

QDRO Acquisition Corp., a blank check company, filed an amended S-1 registration statement for a $200 million initial public offering of units to pursue a business combination in financial services or digital currency and technology sectors.

ContextLogic Holdings Inc. is conducting a rights offering to raise up to $115 million to partially fund its pending $907.5 million acquisition of US Salt Parent Holdings, LLC, a leading evaporated salt producer.

Aptera Motors Corp. files an S-1/A for a $17 million offering of Class B common stock and warrants, detailing its solar electric vehicle development, financial challenges, and recent Nasdaq listing.

Ethos Technologies Inc. has filed an S-1/A for its initial public offering, showcasing significant revenue and policy growth driven by its digital life insurance platform.

Bimergen Energy Corporation files an S-1/A for a public offering of common stock and warrants, seeking NYSE American listing to fund its utility-scale battery energy storage and solar development projects.

ContextLogic Holdings Inc. is conducting a non-transferable subscription rights offering to raise up to $115 million to partially finance its acquisition of US Salt Parent Holdings, LLC.

Farmhouse, Inc. shifts its strategy to a Digital Asset Treasury model, focusing on Bitcoin and Gold, while facing significant financial challenges and relying on a new $20 million equity line.

Revium Rx filed an S-1/A for a self-underwritten public offering of 1.56 million units and a resale of up to 37.6 million common shares by existing stockholders, focusing on lipid-based therapies for antibiotic resistance and cancer.

Estrella Immunopharma, a clinical-stage biopharmaceutical company, filed an S-1/A to register shares for resale, highlighting ongoing clinical trial progress for EB103 and recent capital raises amidst significant operating losses and going concern doubts.

iPower Inc. filed an Amendment No. 1 to its S-1 Registration Statement solely to update certain exhibits, including its list of subsidiaries and financing agreements.

First Choice Healthcare Solutions, Inc. is undergoing a strategic pivot from its legacy orthopedic business to a national chain of primary care and wellness clinics, seeking to raise $12 million through a public offering of Series D Convertible Preferred Stock and warrants.

Inspire Veterinary Partners, a U.S. veterinary hospital operator, is awaiting a Nasdaq delisting decision while pursuing highly dilutive convertible note financing and reporting continued net losses despite some operational improvements.